NanoCytomics
Evanston
About NanoCytomics
NanoCytomics creates a technological platform for the study of nano cytology. They are the creators of a medical innovation aimed at raising the survival rate for cancer patients. The technology developed by their firm enables patients to access creative cancer treatment by providing creative, precise, economical, non-invasive diagnostics for use in primary care. It also uses optical imaging and sensing technologies to explore the architecture and activities of cells. and health services.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $150.0K
- Last round: Grant (May 2012)
- Website: nano-cytomics.com
- Phone: [email protected]
Industries & Categories
Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nanocytomics-3315095 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.